|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 388 EKB-569: a new irreversible inhibitor of epidermal growth factor receptor tyrsine kinase for the treatment of cancer显示文摘 | Discafani C Wang YF Tsou HR Overbeek EG Nilakantan R | 2000 | Clin Cancer Res2000，，： | 1 |
| 2 | mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer显示文摘 | Yu K Toral Barza L Discafani C | 2001 | Endocr Relat Cancer2001，8，3： | 1 |
| 3 | mTOR, a novel target in breast cancer: the effect of CCI- 779, an mTOR inhibitor, in preclinical models of breast cancer 显示文摘 | Yu K Toral-Barza L Discafani C | 2001 | Endocrine-Related Cancer2001，8，3： | 1 |
| 4 | Antitumor Activity of HKI-272,an Orally Active,Irreversible Inhibitor of the HER-2 Tyrosine Kinase显示文摘 | Rabindran S K Discafani C M Rosfjord E C | 2004 | Cancer Res2004，64，11： | 1 |
| 5 | Antitamor activity of HKI-272, an orally active irre- versible inhibitor of the HER-2 tyrosine kinase 显示文摘 | Rabindran S K Discafani C M Rosord E C | 2004 | Cancer Res2004，64，11： | 1 |
| 6 | mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer显示文摘 | Yu K Toral-Barza L Discafani C | 2001 | Endocr Relat Cancer2001，8，3： | 1 |
| 7 | mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast caneer显示文摘 | YU K TORAL-BARZA L DISCAFANI C | 2001 | Endocr Relat Cancer2001，8，3： | 1 |
| 8 | HTI- 286, a synthetic analogue of the tripeptide hemiasterlin,is a potent antimicrotubule agent that circumvents P-glycoprotein- mediated resistance in vitro and in vivo显示文摘 | LOGANZO F DISCAFANI C M ANNABLE T | 2003 | Cancer Res2003，63，8： | 1 |
| 9 | Antitumor activity of HKI - 272, an orally active, irreversible in- hibitor of the HER -2 tyrosine kinase显示文摘 | RABINDRAN S K DISCAFANI C M ROSFJORD E C | 2004 | Cancer Res2004，64，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员